IL17-hæmmere i rampelyset på EULAR 2023
/ Lars Erik Kristensen
BE MOBILE 2: Bimekizumab in patients with active ankylosing spondylitis
/ Désirée van der Heijde
Obese axSpA patients have greater disease activity
/ BestPractice Nordic
Obese patients with axSpA have greater disease activity and spinal stiffness
/ Marco Garrido-Cumbrera
Differential diagnoses in suspected axial SpA
/ Mikkel Østergaard
Update fra EULAR med nye data for spondylartropatier
/ Lars Erik Kristensen
Behandling af SpA – update fra EULAR
/ Lars Erik Kristensen